Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting 2025-09-22 20:00
LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq 2025-09-12 20:00
LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee 2025-09-10 20:10
LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee 2025-08-28 20:00
LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company 2025-08-18 20:00
LakeShore Biopharma Announces US$15 Million Private Placement Financing 2025-07-08 19:25
LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA™ Rabies Vaccine (Vero Cell) 2025-04-23 21:35
LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance 2024-12-19 22:05
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement 2024-10-29 20:30
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine 2024-10-25 20:30
LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance 2024-10-08 20:30
LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation 2024-09-27 19:00
Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024 2024-09-10 20:00
LakeShore Biopharma Announces Leadership Transitions 2024-09-04 20:00
LakeShore Biopharma Announces Leadership Transitions 2024-09-04 20:00
LakeShore Biopharma Announces Financial Results for Fiscal Year 2024 2024-08-15 20:30
LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition 2024-07-05 19:00
1